Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer du pancréas - TOP -128 des médecins

Le Professeur Klaus Kaczirek est un chirurgien endocrinien et oncologue de premier plan, spécialisé dans les tumeurs neuroendocrines à la Wiener Privatklinik.

• Plus de 30 ans d'expérience en chirurgie endocrinienne
• Professeur de chirurgie à l'Université de médecine de Vienne
• Auteur de nombreuses publications sur la biologie des tumeurs endocrines et la chirurgie mini-invasive
• Chef adjoint du département de chirurgie générale à l'hôpital général de Vienne

Le Dr Hossein Taghizadeh est spécialisé dans les cancers du pancréas et des voies biliaires, intégrant des thérapies systémiques modernes à des soins personnalisés à la Wiener Privatklinik.

• Formé à l'Université de médecine de Vienne – l'une des meilleures écoles de médecine d'Autriche
• Expert en chimiothérapie, thérapie ciblée et immunothérapie pour les tumeurs gastro-intestinales
• Se concentrer sur la médecine factuelle et le soutien holistique aux patients
• Travailler avec des outils de diagnostic avancés pour une planification précise du traitement

Le Prof. Dr. med. Karl J. Oldhafer est un expert de premier plan en chirurgie des cancers du pancréas, du foie et de l'estomac à l'hôpital Asklepios Barmbek.

• Médecin-chef en chirurgie générale, viscérale et oncologie chirurgicale
• Diriger un centre des maladies du foie spécialisé dans les interventions hépatiques complexes
• Utiliser des techniques avancées telles que la chirurgie hépatique assistée par ordinateur
• Travailler avec des équipes multidisciplinaires incluant des spécialistes en oncologie et en radiologie
• Se spécialiser dans les techniques de chirurgie abdominale mini-invasive

Le professeur associé Tahsin Ozatli est spécialisé dans le traitement des cancers du sein, du poumon et gastro-intestinaux à l'hôpital universitaire Istinye Liv.

• Expérience acquise dans plusieurs cliniques d'oncologie, y compris des hôpitaux publics et de recherche
• Promu professeur associé en 2016
• Études de médecine à l'université Selcuk de Konya, en Turquie

Formé en chirurgie laparoscopique avancée et bariatrique à l'Université d'Istanbul – un leader des techniques mini-invasives pour le cancer du pancréas.

• Spécialisation en chirurgie laparoscopique depuis 2002
• Formation avancée en chirurgie laparoscopique bariatrique et oncologique
• Formation dans les meilleures institutions médicales turques, notamment l'Université d'Istanbul

Le professeur Gul Alco est spécialisé en radio-oncologie pour le cancer du pancréas à l'Université Medipol d'Istanbul.

• Plus de 20 ans d'expérience en radio-oncologie
• Spécialisation dans le traitement du cancer du pancréas
• Professeur agrégé puis professeur à l'Université Demiroglu Bilim
• Formation approfondie en radio-oncologie

Le professeur agrégé Nail Paksoy est spécialisé dans le traitement du cancer du pancréas à l'hôpital Medipol Bahçelievler, fort de recherches approfondies et d'essais cliniques.

• Certifié par l'ESMO en oncologie médicale
• Sous-investigateur dans des essais cliniques sur le cancer du pancréas, notamment RECITE – AMGEN
• Recherches publiées sur FOLFIRINOX vs Gemcitabine + Nab-Paclitaxel dans le cancer du pancréas
• Formation spécialisée à l'Institut d'oncologie de l'Université d'Istanbul

Spécialisée en virothérapie – l'un des domaines les plus récents de l'immunologie – la Dre Jaunalksne apporte plus de 30 ans d'expérience au traitement du cancer du pancréas.

• Diriger le centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômer de l'Institut médical de Riga avec un internat en médecine interne
• Se concentrer sur les approches immunologiques innovantes contre le cancer

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Spécialisé dans le cancer du pancréas au Medical Park Antalya, formé au prestigieux programme d'oncologie médicale de l'Université Akdeniz.

• Spécialisation en oncologie médicale obtenue en 2018
• Exerce au sein du complexe hospitalier de premier plan Medical Park à Antalya
• Plus de 16 ans d'expérience médicale
• Anciens postes dans des hôpitaux universitaires

Le Dr Ozden apporte plus de 20 ans d'expérience médicale, se spécialisant dans le traitement du cancer du pancréas à l'hôpital VM Medical Park Pendik.

• Diplômé de la prestigieuse faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Spécialisation en oncologie médicale complétée à l'université de Kocaeli
• Vaste expérience en médecine interne avant de se spécialiser en oncologie

Le Dr Auala Hubert est chef du centre de cancérologie gastro-intestinale du centre médical Hadassah – un leader spécialisé dans le traitement des cancers du système digestif, y compris le cancer du pancréas.

• 33 ans d'expertise spécialisée en oncologie et radiothérapie
• Direction d'un centre de cancérologie multidisciplinaire dédié dans un centre hospitalier universitaire de premier plan
• Certification de spécialiste en oncologie médicale et en radiothérapie
• Membre actif du comité national pour le cancer gastro-intestinal
• Double diplôme en médecine et en psychologie

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.